Timothy John Garnett - 10 Feb 2026 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Role
Director
Signature
/s/ Kristopher L. Hanson, Attorney-in-Fact
Issuer symbol
MPLT
Transactions as of
10 Feb 2026
Net transactions value
+$252,678
Form type
4
Filing time
12 Feb 2026, 17:45:08 UTC
Previous filing
28 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Garnett Timothy John Director C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY /s/ Kristopher L. Hanson, Attorney-in-Fact 12 Feb 2026 0001998937

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MPLT Voting Common Stock Purchase $252,678 +14,124 $17.89 14,124 10 Feb 2026 See footnote F1, F2
holding MPLT Voting Common Stock 49,525 10 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.76 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote.
F2 The shares are held by the Timothy J Garnett Revocable Trust Dated U/A 09/22/2021, of which the Reporting Person is the sole trustee and has voting and dispositive power.